[Is cancer a factor or a marker of cardiovascular risk in women?]

Presse Med. 2018 Sep;47(9):780-783. doi: 10.1016/j.lpm.2018.09.004. Epub 2018 Oct 4.
[Article in French]

Abstract

Cardiovascular diseases and cancers are the 2 main causes of mortality in industrialized countries. Cancer and cardiovascular disease share molecular and pathophysiological mechanisms involved in both cardiovascular disease and cancer development. Some prescribed therapies for primary or secondary prevention of cardiovascular disease (statin, aspirin) may have effects on the cancer plan. Physical activity would be particularly beneficial in reducing the risk of colorectal cancer, breast and endometrial cancer in women. The control of risk factors is associated with a reduction in the incidence of cancers.

Publication types

  • Review

MeSH terms

  • Aspirin / therapeutic use
  • Biomarkers*
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / etiology*
  • Chemoprevention / methods
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Incidence
  • Neoplasms / complications*
  • Neoplasms / epidemiology*
  • Neoplasms / prevention & control
  • Risk Factors
  • Secondary Prevention
  • Sex Factors

Substances

  • Biomarkers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Aspirin